Skip to main content

PIER 88 INVESTMENT PARTNERS LLC

Position in DNLI — Denali Therapeutics Inc.

CIK 1697366 SAN FRANCISCO, CA

Position in DNLI

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$1,244,160
+$118,178 QoQ
Shares Held
64,800
-5.0% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

PIER 88 INVESTMENT PARTNERS LLC holds $8,185,124 across 11 Biotechnology names. DNLI ranks #2 (15.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 DNLI
Denali Therapeutics Inc.
This page
64,800 $1,244,160

All Filings in DNLI

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,244,160 64,800
2025-12-31 $1,125,982 68,200
2025-09-30 $979,228 67,440
2025-06-30 $799,528 57,150
2025-03-31 $610,551 44,910
2024-12-31 $925,455 45,410
2024-09-30 $1,723,622 59,170
2024-06-30 $1,610,771 69,370
2024-03-31 $820,184 39,970
2023-12-31 $970,850 45,240
2023-09-30 $1,045,941 50,700
2023-06-30 $1,407,036 47,680
2023-03-31 $987,033 42,840
2022-12-31 $980,024 35,240
2022-09-30 $371,042 12,090
2022-06-30 $384,944 13,080
2022-03-31 $321 10
2021-12-31 $1,475,368 33,080
2021-09-30 $952,495 18,880
2021-06-30 $1,107,572 14,120
2021-03-31 $431,676 7,560
2020-12-31 $1,074,222 12,825
2020-09-30 $1,282,534 35,795
2020-06-30 $1,264,831 52,309
2020-03-31 $835,227 47,700